__NUXT_JSONP__("/drugs/Nendratareotide_Uzatansine", (function(a,b,c,d){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1853254-97-3",chebiId:b,chemicalFormula:b,definition:"A miniaturized drug conjugate composed of a peptide analog of somatostatin that targets the somatostatin receptor 2 (SSTR2) and is conjugated, through a cleavable linker, to the microtubule-binding cytotoxic maytansinoid DM1 (mertansine), with potential anti-tumor activity. Upon administration, the peptide ligand moiety of nendratareotide uzatansine targets and binds to SSTR2, which is overexpressed on certain tumor cell types. Binding stimulates SSTR2-mediated endocytosis of the agent; upon internalization, the DM1 moiety is released and binds to tubulin, thereby disrupting microtubule assembly\u002Fdisassembly dynamics. This inhibits both cell division and the proliferation of SSTR2-expressing cancer cells. Compared to antibody-drug conjugates (ADCs), miniaturized drug conjugates are much smaller and can more easily penetrate and distribute in dense tumor tissue.",fdaUniiCode:"L8993M383E",identifier:"C131562",preferredName:c,semanticType:"Pharmacologic Substance",subclassOf:["C575"],synonyms:["NENDRATAREOTIDE UZATANSINE",c,"PEN 221","PEN-221","PEN221","SSTR2-targeting Protein\u002FDM1 Conjugate PEN-221","SSTR2PEN-221"]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FNendratareotide_Uzatansine",extension:".json",createdAt:d,updatedAt:d}}],fetch:{},mutations:void 0}}("Nendratareotide_Uzatansine","","Nendratareotide Uzatansine","2021-10-30T13:31:26.903Z")));